Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2018

01-08-2018 | Original Article

HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection

Authors: Lisa Li, David Puddicombe, Sylvie Champagne, Agatha Jassem, Mel Krajden, Linda Merrick, Christopher Lowe, Michael Payne

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2018

Login to get access

Abstract

Early and rapid detection of patients with HIV is a key to preventing further transmission. The purpose of this study was to assess the ability of signal-to-cutoff (S/CO) ratio from initial screening fourth-generation HIV serology to predict subsequent confirmation of HIV. Patients with a first-time positive HIV serology (S/CO ratio ≥ 1) from 2012 to 2016 were included. Ratios were compared to the results of confirmatory testing. Predictive probabilities (PPs) of a positive confirmatory result were calculated based on a logistic regression model. A total of 45,138 HIV serology tests were performed; 250 patients met inclusion criteria, comprising 84 (34%) HIV negative patients, 136 (54%) chronic infections, and 30 (12%) acute infections. The PP of a confirmed positive result increased with higher S/CO ratios, with a PP of 100% for a S/CO of 55 (95% CI 95–100). This study enables a more informed discussion of the probability of HIV infection, based on HIV serology S/CO thresholds, prior to a confirmatory result.
Literature
2.
go back to reference Hollingsworth TD, Anderson RM, Fraser C (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198(5):687–693CrossRefPubMed Hollingsworth TD, Anderson RM, Fraser C (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198(5):687–693CrossRefPubMed
5.
go back to reference Jensen TO, Robertson P, Whybin R, Chambers I, Lahra M, Rawlinson W et al (2015) A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting. J Clin Microbiol 53(5):1709–1711CrossRefPubMedPubMedCentral Jensen TO, Robertson P, Whybin R, Chambers I, Lahra M, Rawlinson W et al (2015) A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting. J Clin Microbiol 53(5):1709–1711CrossRefPubMedPubMedCentral
6.
go back to reference Ramos EM, Harb S, Dragavon J, Swenson P, Stekler JD, Coombs RW (2013) Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection. J Clin Virol 58(Suppl 1):e38–e43CrossRefPubMedPubMedCentral Ramos EM, Harb S, Dragavon J, Swenson P, Stekler JD, Coombs RW (2013) Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection. J Clin Virol 58(Suppl 1):e38–e43CrossRefPubMedPubMedCentral
7.
go back to reference Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L et al (2010) The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med 20(3):152–159CrossRefPubMed Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L et al (2010) The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Transfus Med 20(3):152–159CrossRefPubMed
8.
go back to reference Chavez P, Wesolowski L, Patel P, Delaney K, Owen SM (2011) Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 52(Suppl 1):S51–S55CrossRefPubMed Chavez P, Wesolowski L, Patel P, Delaney K, Owen SM (2011) Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 52(Suppl 1):S51–S55CrossRefPubMed
9.
go back to reference Kim S, Lee JH, Choi JY, Kim JM, Kim HS (2010) False-positive rate of a “fourth-generation” HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 17(10):1642–1644CrossRefPubMedPubMedCentral Kim S, Lee JH, Choi JY, Kim JM, Kim HS (2010) False-positive rate of a “fourth-generation” HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 17(10):1642–1644CrossRefPubMedPubMedCentral
10.
go back to reference Chacon L, Mateos ML, Holguin A (2017) Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting. J Clin Virol 92:11–13CrossRefPubMed Chacon L, Mateos ML, Holguin A (2017) Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting. J Clin Virol 92:11–13CrossRefPubMed
11.
go back to reference Bhattacharya R, Barton S, Catalan J (2008) When good news is bad news: psychological impact of false positive diagnosis of HIV. AIDS Care 20(5):560–564CrossRefPubMed Bhattacharya R, Barton S, Catalan J (2008) When good news is bad news: psychological impact of false positive diagnosis of HIV. AIDS Care 20(5):560–564CrossRefPubMed
12.
go back to reference McInnes CW, Druyts E, Harvard SS, Gilbert M, Tyndall MW, Lima VD et al (2009) HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J 6:5CrossRefPubMedPubMedCentral McInnes CW, Druyts E, Harvard SS, Gilbert M, Tyndall MW, Lima VD et al (2009) HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J 6:5CrossRefPubMedPubMedCentral
Metadata
Title
HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection
Authors
Lisa Li
David Puddicombe
Sylvie Champagne
Agatha Jassem
Mel Krajden
Linda Merrick
Christopher Lowe
Michael Payne
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3290-y

Other articles of this Issue 8/2018

European Journal of Clinical Microbiology & Infectious Diseases 8/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine